Literature DB >> 12842230

Pharmacological management of tics in patients with TS.

Paul Sandor1.   

Abstract

This article reviews the evidence published in the English language literature concerning the pharmacological treatment of tics in patients with Tourette Syndrome. The focus is on the efficacy and safety of the current treatments. A clinical approach to pharmacological management of Tourette Syndrome patients is outlined.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12842230     DOI： 10.1016/s0022-3999(03)00060-6

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN： 0022-3999            Impact factor:   3.006


  10 in total

1.  Carbidopa-levodopa-induced recrudescence of premorbid tic disorder in remission.

Authors:  Tariq Latif; Raphael J Leo; Yogesh D Bakhai
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

2.  Tourette's syndrome in children.

Authors:  Uttom Chowdhury; Isobel Heyman
Journal:  BMJ       Date:  2004-12-11

3.  Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.

Authors:  Michele P Kelly; Carolina Isiegas; York-Fong Cheung; Jan Tokarczyk; Xioaju Yang; Michael F Esposito; David A Rapoport; Sara A Fabian; Steven J Siegel; Gary Wand; Miles D Houslay; Stephen J Kanes; Ted Abel
Journal:  Neuropsychopharmacology       Date:  2006-05-31       Impact factor: 7.853

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

5.  Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis.

Authors:  Aihua Yuan; Liang Su; Shunying Yu; Chunbo Li; Tao Yu; Jinhua Sun
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

Review 6.  Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders.

Authors:  Xue Ming; Martha Mulvey; Sharanya Mohanty; Viraj Patel
Journal:  Adolesc Health Med Ther       Date:  2011-09-30

7.  An International Survey of Health Care Services Available to Patients With Tourette Syndrome.

Authors:  Tracy Bhikram; Rana Elmaghraby; Elia Abi-Jaoude; Paul Sandor
Journal:  Front Psychiatry       Date:  2021-02-26       Impact factor: 4.157

8.  New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6.

Authors:  Rafael Garcia-Lopez; Emilio Perea-Milla; Cesar Ruiz Garcia; Francisco Rivas-Ruiz; Julio Romero-Gonzalez; Jose L Moreno; Vicente Faus; Guadalupe del Castillo Aguas; Juan C Ramos Diaz
Journal:  Trials       Date:  2009-03-10       Impact factor: 2.279

9.  Outpatient Treatment of Tic Disorders Among Children and Adults.

Authors:  Joseph L Smith; Sean Gregory; Nicole McBride; Tanya K Murphy; Eric A Storch
Journal:  Mov Disord Clin Pract       Date:  2017-03-11

10.  Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.

Authors:  Alessandro S De Nadai; Eric A Storch; Joseph F McGuire; Adam B Lewin; Tanya K Murphy
Journal:  J Cent Nerv Syst Dis       Date:  2011-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.